FDA issues Myfortic tablets safety alert

Nov 28, 2007

The U.S. Food and Drug Administration issued a safety alert for pregnant patients using the kidney transplant drug Myfortic delayed-release tablets.

The FDA said it has been determined the medication is associated with increased risks of pregnancy loss and congenital malformations. Officials said the pregnancy category for Myfortic has been changed to Category D -- positive evidence of fetal risk.

Myfortic is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids.

The FDA said a transplant patient planning a pregnancy shouldn't use Myfortic unless she cannot be successfully treated with other immunosuppressant drugs.

Myfortic is manufactured by Novartis Pharmaceuticals.

Copyright 2007 by United Press International

Explore further: Drug prices to treat multiple sclerosis soar, point to larger problem

Related Stories

In the realm of eternal ice

47 minutes ago

On 6 November 2010, the light of the star known as NOMAD1 0856-0015072 in the Cetus constellation dimmed. What had happened? A dwarf planet at the edge of the solar system had moved in front of the distant ...

Understanding 'secret' urban languages

1 hour ago

Research into a 'playful' and increasingly popular urban language that grew out of the necessity for criminals to hide their true intent could help organisations in Uganda communicate better with the country's ...

Test can smell ketosis

1 hour ago

VTT has developed a quick, easy-to-use ketosis test for consumers that can detect acetone on exhaled breath. The test will benefit diabetics and dieters in particular, but it can easily be adapted to other uses as well, such ...

Recommended for you

Rising antibiotic shortages raise concerns about patient care

Apr 23, 2015

Shortages of key antibiotics, including gold-standard therapies and drugs used to treat highly resistant infections, are on the rise, according to a new study of shortages from 2001 to 2013 published in Clinical Infectious Di ...

Study supports HPV vaccination guidelines

Apr 21, 2015

(HealthDay)—New research finds that young women who get the HPV vaccine gain significant protection against infection in three parts of the body if they haven't already been exposed to the human papillomavirus.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.